Cargando…
MIR29A Impedes Metastatic Behaviors in Hepatocellular Carcinoma via Targeting LOX, LOXL2, and VEGFA
Primary liver cancer accounts for the third most deadly type of malignant tumor globally, and approximately 80% of the cases are hepatocellular carcinoma (HCC), which highly relies on the activity of hypoxia responsive pathways to bolster its metastatic behaviors. MicroRNA-29a (MIR29A) has been show...
Autores principales: | Yang, Ya-Ling, Tsai, Ming-Chao, Chang, Yen-Hsiang, Wang, Chen-Chen, Chu, Pei-Yi, Lin, Hung-Yu, Huang, Ying-Hsien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8199573/ https://www.ncbi.nlm.nih.gov/pubmed/34206143 http://dx.doi.org/10.3390/ijms22116001 |
Ejemplares similares
-
New Insights into the Role of miR-29a in Hepatocellular Carcinoma: Implications in Mechanisms and Theragnostics
por: Yang, Ya-Ling, et al.
Publicado: (2021) -
The interaction of LOXL2 with GATA6 induces VEGFA expression and angiogenesis in cholangiocarcinoma
por: Peng, Tao, et al.
Publicado: (2019) -
Azithromycin Attenuates Bleomycin-Induced Pulmonary Fibrosis Partly by Inhibiting the Expression of LOX and LOXL-2
por: Tong, Xiang, et al.
Publicado: (2021) -
Dihydroartemisinin Potentiates VEGFR-TKIs Antitumorigenic Effect on Osteosarcoma by Regulating Loxl2/VEGFA Expression and Lipid Metabolism Pathway
por: Ding, Xiaomin, et al.
Publicado: (2023) -
The effect of LOXL2 in hepatocellular carcinoma
por: Wu, Linghong, et al.
Publicado: (2016)